AI-generated from publicly available materials.Telemedicine is significantly reshaping cancer care at MD Anderson, with virtual visits now comprising 25% of ambulatory encounters.
The University of Texas MD Anderson Cancer Center reported over 295,000 virtual consultations in fiscal 2026, with 60% of patients utilizing telemedicine. This shift is helping the institution evaluate the effectiveness and limitations of virtual care in oncology, aiming for a comprehensive integration across various treatment areas. Dr. Neema Navai emphasized that while physical presence is essential for certain procedures, telemedicine can be applied broadly, allowing for a more flexible approach to patient care.
To enhance accessibility, MD Anderson has established a dedicated team to handle out-of-state licensure, enabling them to reach patients across geographical barriers. This initiative, which gained momentum during the COVID-19 pandemic, facilitates ongoing care through telemedicine. Furthermore, research indicates that telemedicine is effective in recruiting patients for clinical trials, with comparable enrollment rates for those assessed virtually versus in person.
Another benefit of virtual care is the potential for earlier patient engagement, which can expedite the initiation of cancer-directed therapies. Dr. Navai pointed out that timely access to information allows clinicians to act swiftly, improving treatment workflows. However, challenges such as broadband access and the need for appropriate medical devices remain obstacles to widespread adoption.
MD Anderson is now exploring a transformative approach to its care models, considering how telemedicine can fundamentally alter the delivery of care rather than merely fitting into existing frameworks. This forward-thinking mindset could lead to significant advancements in patient-centered cancer treatment.